scispace - formally typeset
R

Robert F. Lemanske

Researcher at University of Wisconsin-Madison

Publications -  339
Citations -  29528

Robert F. Lemanske is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Asthma & Allergy. The author has an hindex of 86, co-authored 337 publications receiving 27178 citations. Previous affiliations of Robert F. Lemanske include Allegheny General Hospital & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Wheezing Rhinovirus Illnesses in Early Life Predict Asthma Development in High-Risk Children

TL;DR: Among outpatient viral wheezing illnesses in infancy and early childhood, those caused by RV infections are the most significant predictors of the subsequent development of asthma at age 6 years in a high-risk birth cohort.
Journal ArticleDOI

Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome

TL;DR: Criteria for defining asthma endotypes on the basis of their phenotypes and putative pathophysiology are suggested and how these new definitions can be used in clinical study design and drug development to target existing and novel therapies to patients most likely to benefit are proposed.
Journal ArticleDOI

Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations

Dara G. Torgerson, +79 more
- 01 Sep 2011 - 
TL;DR: The results suggest that some asthma susceptibility loci are robust to differences in ancestry when sufficiently large samples sizes are investigated, and that ancestry-specific associations also contribute to the complex genetic architecture of asthma.
Journal ArticleDOI

Role of viral respiratory infections in asthma and asthma exacerbations

TL;DR: There is evidence that deficiencies in antiviral activity and the integrity of the airway epithelial barrier could make individuals with asthma more likely to have severe viral respiratory infections of the lower airway, and thus increase the risk of exacerbation.